METONITAZENE HYDROCHLORIDE CAS: 3983-24-2

CAS NO: 3983-24-2
METONITAZENE HYDROCHLORIDE
Chemical Name: 1H-Benzimidazole-1-ethanamine, N,N-diethyl-2-[(4-methoxyphenyl)methyl]-5-nitro-, hydrochloride (1:1)
Molecular Formula: C21H27ClN4O3
Formula Weight: 418.92
CAS No.: 3983-24-2
Description Review
Description

Metonitazene Hydrochloride is an opioid analgesic drug belonging to the benzimidazole class. It is derived from the synthetic opioid etonitazene and was first developed in the 1950s. Its chemical name is 1-(2-(2-fluorophenyl)-7,8-dihydro-5H-[1,3]benzodioxolo[5,6-b]azepin-3-yl)propan-2-amine hydrochloride, while its molecular formula is C22H26ClFN2O2, with a formula weight of 416.9 g/mol. Its CAS number is 3983-24-2.

Top Ten Keywords from Google and Synonyms

  1. Metonitazene effects
  2. Metonitazene dosage
  3. Benzimidazole class
  4. Opioid analgesic
  5. Research Chemical
  6. Synthetic opioids
  7. Etazen
  8. Etitonazene
  9. Metonitazene trip report
  10. Legal high

Health Benefits of Metonitazene Hydrochloride

There are no health benefits associated with Metonitazene Hydrochloride as it is not approved for human use. It is only used in research and experimental settings.

Potential Effects of Metonitazene Hydrochloride

Metonitazene Hydrochloride is an opioid analgesic that can cause significant euphoria and feelings of relaxation. It is highly addictive and can cause significant physical and psychological dependence. Metonitazene also causes respiratory depression, which can lead to coma or death in high doses.

Product Mechanism

The product mechanism of Metonitazene Hydrochloride is its ability to bind to and activate the mu-opioid receptors in the brain and spinal cord. This action leads to decreased sensitivity to pain, a feeling of relaxation, and euphoria.

Safety

Metonitazene Hydrochloride is not safe for human use, and its long-term effects are unknown. Its use can lead to significant physical and psychological dependence, and withdrawal symptoms upon cessation. It is important to follow proper laboratory protocols and safety procedures when handling this substance.

Side Effects

The use of Metonitazene Hydrochloride can cause several harmful side effects, including respiratory depression, constipation, euphoria, an altered state of consciousness, confusion, dizziness, and nausea. Prolonged use can also lead to addiction and withdrawal symptoms.

Dosing Information

There is no established dosing information for Metonitazene Hydrochloride since it is not approved for human use. Substances like this should only be handled and administered by professionals with experience and appropriate safety protocols

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code